HK Stock Market Move | KINTOR PHARMA-B (09939) increased by over 5% in early trading, joining hands with CHICMAX to accelerate the commercialization of KT-939 whitening cosmetics ingredients.

KINTOR PHARMA-B (09939) rose by more than 5% in the morning session, up 5.54% to 4.38 Hong Kong dollars as of the time of writing, with a trading volume of 1.99 million Hong Kong dollars. On the news front, Kintor Pharma announced that its wholly-owned subsidiary has entered into a strategic cooperation framework agreement with CHICMAX (02145) in the field of cosmetics, including exclusive clauses. The two parties will collaborate deeply on the development of KT-939, a raw material for whitening and spot removal cosmetics under Kintor Pharma, to accelerate its commercialization and jointly create the "strongest domestically produced whitening agent" with industry influence.